[FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
D000933:Antifibrinolytic Agents; D001791:Blood Platelet Disorders; D001797:Blood Protein Electrophoresis; D003850:Deoxyribonuclease I; D004791:Enzyme Inhibitors; D005340:Fibrinogen; D005341:Fibrinolysin; D005342:Fibrinolysis; D011086:Polycythemia; D055728:Primary Myelofibrosis; D012712:Serum Globulins; D013025:Glycine max; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D013917:Thrombin; D014357:Trypsin; D005719:gamma-Globulins
D000933:Antifibrinolytic Agents; D004791:Enzyme Inhibitors; D012712:Serum Globulins; D005719:gamma-Globulins; D005340:Fibrinogen; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D014357:Trypsin; D013917:Thrombin; D005341:Fibrinolysin
BLOOD PLATELET DISORDERS; BLOOD PROTEIN ELECTROPHORESIS; ENZYME INHIBITORS; FIBRINOLYSIN; GAMMA GLOBULIN; MYELOFIBROSIS; POLYCYTHEMIA; SERUM GLOBULINS; SOY BEANS; STREPTODORNASE AND STREPTOKINASE; TRYPSIN
LES INHIBITEURS DE LA FIBRINOLYSE ET LE DOSAGE DE L'ACTIVIT'E ANTIPLASMINIQUE PHYSIOLOGIQUE ET PATHOLOGIQUE.